The FDA explains that GLP-1 receptor agonists mimic the effects of a natural hormone released by the intestine, help lower blood sugar after eating, and act on brain regions involved in appetite and food intake

Acronyms A1C - Hemoglobin A1C ADA - American Diabetes Association CVD - Cardiovascular disease DM - Diabetes mellitus FBS - Fasting blood sugar GFR - Glomerular filtration rate GI - Gastrointestinal GLP-1 - Glucagon-like peptide-1 OSA - Obstructive sleep apnea RCT - Randomized controlled trial T2DM - Type 2 diabetes mellitus Thyroid C-cell tumor = Thyroid medullary tumor DRUGS IN CLASS Dual GLP-1 and GIP agonists Tirzepatide (Mounjaro) - marketed for diabetes Tirzepatide (Zepbound) - marketed for weight loss MECHANISM OF ACTION GLP-1 and GIP GLP-1 stands for "glucagon-like peptide-1," and GIP stands for "glucose-dependent insulinotropic polypeptide." GIP is also sometimes referred to as "gastric inhibitory polypeptide." GLP-1 and GIP are hormones secreted by specialized cells in the small intestine in response to food consumption
52 Meal Patterns: Smaller, more frequent meals may be easier on the digestive system for both issues
Learn more about Nelumbo Nucifera Flower Extract Lilium Tigrinum Extract comes from the Lily flower native to east Asia
Age, baseline metabolic rate, concurrent medications, and lifestyle factors also influence results
Patients taking other glucose-lowering agents may experience more rapid glycemic improvements, though this must be balanced against increased hypoglycemia risk when combined with insulin or sulfonylureas